235 related articles for article (PubMed ID: 24030252)
21. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites.
Eleswarapu S; Gu Z; Jiang H
Endocrinology; 2008 May; 149(5):2230-40. PubMed ID: 18276757
[TBL] [Abstract][Full Text] [Related]
23. Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements.
Huang Y; Kim SO; Yang N; Jiang J; Frank SJ
Mol Endocrinol; 2004 Jun; 18(6):1471-85. PubMed ID: 15044591
[TBL] [Abstract][Full Text] [Related]
24. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
25. Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B.
Choi JH; Kim HS; Kim SH; Yang YR; Bae YS; Chang JS; Kwon HM; Ryu SH; Suh PG
Nat Cell Biol; 2006 Dec; 8(12):1389-97. PubMed ID: 17128263
[TBL] [Abstract][Full Text] [Related]
26. The role of prolactin receptor in GH signaling in breast cancer cells.
Xu J; Sun D; Jiang J; Deng L; Zhang Y; Yu H; Bahl D; Langenheim JF; Chen WY; Fuchs SY; Frank SJ
Mol Endocrinol; 2013 Feb; 27(2):266-79. PubMed ID: 23192981
[TBL] [Abstract][Full Text] [Related]
27. Regulation of growth hormone induced JAK2 and mTOR signalling by hepatic protein tyrosine phosphatase 1B.
Owen C; Lees EK; Mody N; Delibegović M
Diabetes Metab; 2015 Feb; 41(1):95-101. PubMed ID: 24948418
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes.
Shumate ML; Yumet G; Ahmed TA; Cooney RN
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G227-39. PubMed ID: 15831712
[TBL] [Abstract][Full Text] [Related]
29. Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature.
Ocaranza P; Gaete X; Román R; Morales F; Íñiguez G; Cassorla F
J Pediatr Endocrinol Metab; 2013; 26(9-10):833-40. PubMed ID: 23729600
[TBL] [Abstract][Full Text] [Related]
30. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor-1 (IGF-1) receptor-insulin receptor substrate complexes in the uterus. Altered signaling response to estradiol in the IGF-1(m/m) mouse.
Richards RG; Walker MP; Sebastian J; DiAugustine RP
J Biol Chem; 1998 May; 273(19):11962-9. PubMed ID: 9565625
[TBL] [Abstract][Full Text] [Related]
32. Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells.
Manabe N; Kubota Y; Kitanaka A; Ohnishi H; Taminato T; Tanaka T
Leuk Res; 2006 Nov; 30(11):1391-8. PubMed ID: 16650892
[TBL] [Abstract][Full Text] [Related]
33. Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.
Frost RA; Nystrom GJ; Lang CH
Endocrinology; 2002 Feb; 143(2):492-503. PubMed ID: 11796503
[TBL] [Abstract][Full Text] [Related]
34. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
[TBL] [Abstract][Full Text] [Related]
35. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.
Johnson KJ; Peck AR; Liu C; Tran TH; Utama FE; Sjolund AB; Schaber JD; Witkiewicz AK; Rui H
Am J Pathol; 2010 Dec; 177(6):2971-83. PubMed ID: 20952588
[TBL] [Abstract][Full Text] [Related]
36. SIRT1 regulates adaptive response of the growth hormone--insulin-like growth factor-I axis under fasting conditions in liver.
Yamamoto M; Iguchi G; Fukuoka H; Suda K; Bando H; Takahashi M; Nishizawa H; Seino S; Takahashi Y
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14948-53. PubMed ID: 23980167
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
38. Growth Hormone Induces Colon DNA Damage Independent of IGF-1.
Chesnokova V; Zonis S; Barrett RJ; Gleeson JP; Melmed S
Endocrinology; 2019 Jun; 160(6):1439-1447. PubMed ID: 31002310
[TBL] [Abstract][Full Text] [Related]
39. Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes.
Zhang Y; Liu Y; Li X; Gao W; Zhang W; Guan Q; Jiang J; Frank SJ; Wang X
Lipids Health Dis; 2013 Apr; 12():56. PubMed ID: 23631823
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
